1. Home
  2. INAB vs INHD Comparison

INAB vs INHD Comparison

Compare INAB & INHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • INHD
  • Stock Information
  • Founded
  • INAB 2016
  • INHD 2019
  • Country
  • INAB United States
  • INHD United States
  • Employees
  • INAB N/A
  • INHD N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • INHD
  • Sector
  • INAB Health Care
  • INHD
  • Exchange
  • INAB Nasdaq
  • INHD Nasdaq
  • Market Cap
  • INAB 18.8M
  • INHD 19.8M
  • IPO Year
  • INAB 2021
  • INHD 2023
  • Fundamental
  • Price
  • INAB $0.19
  • INHD $7.03
  • Analyst Decision
  • INAB Strong Buy
  • INHD
  • Analyst Count
  • INAB 2
  • INHD 0
  • Target Price
  • INAB $3.60
  • INHD N/A
  • AVG Volume (30 Days)
  • INAB 786.0K
  • INHD 39.1K
  • Earning Date
  • INAB 05-08-2025
  • INHD 05-12-2025
  • Dividend Yield
  • INAB N/A
  • INHD N/A
  • EPS Growth
  • INAB N/A
  • INHD N/A
  • EPS
  • INAB N/A
  • INHD N/A
  • Revenue
  • INAB N/A
  • INHD $916,878.00
  • Revenue This Year
  • INAB N/A
  • INHD N/A
  • Revenue Next Year
  • INAB N/A
  • INHD N/A
  • P/E Ratio
  • INAB N/A
  • INHD N/A
  • Revenue Growth
  • INAB N/A
  • INHD 39.48
  • 52 Week Low
  • INAB $0.13
  • INHD $3.00
  • 52 Week High
  • INAB $1.74
  • INHD $10.23
  • Technical
  • Relative Strength Index (RSI)
  • INAB 49.14
  • INHD 67.11
  • Support Level
  • INAB $0.15
  • INHD $5.22
  • Resistance Level
  • INAB $0.18
  • INHD $10.23
  • Average True Range (ATR)
  • INAB 0.02
  • INHD 0.60
  • MACD
  • INAB 0.01
  • INHD 0.24
  • Stochastic Oscillator
  • INAB 93.22
  • INHD 47.47

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About INHD Inno Holdings Inc.

Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.

Share on Social Networks: